List view / Grid view
22 October 2014 | By APO (African Press Organization) on behalf of The Economist Events
The Economist Events will be hosting their Health Care in Africa Summit in Dar es Salaam, Tanzania at the Hyatt Regency, The Kilimanjaro on November 18th and 19th 2014...
22 October 2014 | By Roche
Investments of 3 billion Swiss francs in modern research infrastructure, attractive workplaces and sustainable site development...
22 October 2014 | By Frost & Sullivan
Etienne van Wyk, Programme Manager for Healthcare at Frost & Sullivan Africa, comments on the current outbreak and its long term implications...
21 October 2014 | By Boehringer Ingelheim
Boehringer Ingelheim today announced the enrolment of the first patient in a new global Phase III study in patients with advanced colorectal cancer...
Sartorius, a leading international laboratory and pharmaceutical equipment supplier, successfully closed the first nine months of 2014 with substantial gains.
21 October 2014 | By Calixar
Aston University (Birmingham - UK) and Calixar SAS (Lyon-France) have concluded a new research agreement through the “BBSRC Industrial CASE Studentship Competition 2013” framework...
21 October 2014 | By Amgen
Amgen announced the appointment of R. Sanders Williams, M.D., president of Gladstone Institutes and Gladstone's Robert W. and Linda L. Mahley Distinguished Professor...
21 October 2014 | By The European Medicines Agency
EMA encourages companies to apply for orphan designation...
20 October 2014 | By Doctors of the World UK
A new report by the think-tank Demos, supported by Doctors of the World, argues that encouraging earlier detection of health conditions amongst migrant communities would reduce NHS spending on treatment and reduce the wider public health risk by catching transmittable diseases early...
20 October 2014 | By SBRI Healthcare
Funding will accelerate development and NHS adoption of new technologies...
20 October 2014 | By Masters Speciality Pharma
Masters Speciality Pharma celebrates the anniversary of its foundation by Dr Zulf Masters, OBE, 30 years ago...
20 October 2014 | By Janssen
Janssen-Cilag International NV (Janssen) announced today that the European Commission has approved IMBRUVICA™ (ibrutinib) capsules, a first-in-class, once-daily, oral Bruton’s tyrosine kinase (BTK) inhibitor.
20 October 2014 | By Abbott
Abbott was named one of the Top 20 Employers by the journal Science...
20 October 2014 | By Nasdaq
Nasdaq announced that trading of Forward Pharma A/S (Nasdaq: FWP) commenced on The Nasdaq Stock Market on October 15, 2014....
20 October 2014 | By AstraZeneca
AstraZeneca, together with its global biologics research and development arm, MedImmune, announced that it has entered into four new collaborations with the University of Cambridge, building further on their existing partnership...
